The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

Blog
Dr Liz Moore at the conference
Monday 23 July 2018
Earlier this month, our nurse advisers Joan and Val attended the annual meeting of the British Gynaecological Cancer Society (BGCS), the UK’s largest conference dedicated to gynaecological cancer. The conference was attended by over 450 scientists, doctors, nurses and patients. Joan and Val spent...
Blog
Doctor writing a prescription
Friday 1 June 2018
The National Institute for Health and Care Excellence (NICE) has approved Niraparib (Zejula®), a revolutionary new ovarian cancer drug for use in England on the Cancer Drugs Fund (CDF). We, together with our supporters, have worked hard to campaign for this announcement. I know what this means for...
Blog
Jane
Thursday 31 May 2018
Jane Howarth, 54 from Manchester, was diagnosed with advanced ovarian cancer in 2015. She has been taking niraparib for nine months. This is her story in her own words... “Every night I swallow two pills to control my advanced, recurrent ovarian cancer. The cancer I am told is now incurable. The...
Blog
A woman and her daughter
Wednesday 30 May 2018
About 15 to 20 per cent of cases of ovarian cancer are caused by a genetic mutation and the most common gene mutations are those in either the BRCA1 or BRCA2 genes. Women in the general population have a two per cent risk of developing ovarian cancer; for women with a BRCA1 mutation this rises to...

Pages